Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Future Genomics Technologies is a Netherlands-based genomics technology company that provides custom sequencing, genome assembly, transcriptomics, transgene integration analysis, methylation analysis, and related bioinformatics services. Founded in 2017, the company was created as a collaboration between BaseClear and Leiden University to translate advanced academic genomics methods into practical applications. Its capabilities are centered on next-generation sequencing, especially Oxford Nanopore long-read sequencing, alongside Illumina-based workflows. The company serves biotechnology, biopharmaceutical, academic, agro, and food-sector customers rather than operating as a traditional therapeutics developer. It appears to function primarily as a commercial genomics services and platform company rather than a drug pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Future Genomics Technologies.